Growth hormone shows promise in shrinking HIV's secret hideout
NCT ID NCT03091374
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This study tested whether giving recombinant human growth hormone for 48 weeks could reduce the hidden HIV reservoir in 22 adults already on successful antiretroviral therapy (ART). The goal was to see if this approach could help the immune system naturally control the virus, moving toward a functional cure. Participants were HIV-positive adults under 40 with undetectable viral loads and healthy immune cell counts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mcgill University Health Center
Montreal, Quebec, H4A 3J1, Canada
Conditions
Explore the condition pages connected to this study.